Objective The present study was performed to clarify the ability of ultrasonography (US) and computed tomography (CT) 
Introduction

Nonalcoholic fatty liver disease (NAFLD) is increasingly being recognized as the most common cause of chronic liver disease worldwide. NAFLD represents a wide spectrum of conditions, ranging from simple steatosis that generally follows a benign and nonprogressive clinical course to nonalcoholic steatohepatitis (NASH), which sometimes progresses to cirrhosis and hepatocellular carcinoma (HCC)
. In Japan, annual health checks have shown that 10-30% of Japanese adults demonstrate evidence of NAFLD by ultrasonography (US) (6, 7) . It has been reported that almost 10% of persons with NAFLD will have NASH, so the prevalence of NASH is estimated at 1-3% of the adult Japanese population, an extremely large number of potential patients. Unfortunately, there are no accurate noninvasive diagnostic methods for NASH, such as biochemical markers or imaging techniques, therefore liver biopsy is necessary to make a definite diagnosis, although the procedure is associated with pain, risks, high cost, and sampling errors (1, 2, (8) (9) (10) (11) .
In general practice, NAFLD (which includes simple steatosis and NASH) is a convenient term for the diagnosis and management of these patients. Diagnosis of NAFLD is based on the detection of steatosis by imaging techniques and the exclusion of other liver diseases, such as alcoholic liver disease or viral hepatitis. The response of NAFLD to treatment is usually evaluated by the changes in transaminases and from imaging findings. Therefore, imaging studies are extremely important, both for diagnosing NAFLD and for monitoring patients over time.
Abdominal US is currently the most common method employed for qualitative assessment of hepatic steatosis, because it is noninvasive, widely available, cheap, and provides useful information (12) . Computed tomography (CT) scanning and magnetic resonance imaging (MRI) both seem to be sensitive techniques for the quantification of steatosis, but MRI is still less widely available and more expensive than CT. In general practice, therefore, detection of steatosis is generally done by US, after which CT is performed for more objective and quantitative assessment of the severity of steatosis based on the liver/spleen attenuation ratio (13) .
Several studies have assessed the sensitivity, specificity, and positive and negative predictive value of US for detecting steatosis, and the reported sensitivity ranges around 80-100% (8) (9) (10) 12 (12, 22) .
CT was performed with a multi-detector row helical scanner. On non-enhanced scans, the liver-to-spleen attenuation ratio was measured and the presence of steatosis was indicated by a ratio of less than 0.9 according Japanese criteria (13) T a b l e 1 . P a t i e n t P r o f i l e (Fig. 3) Moderate to severe steatosis ; n=88 F i g u r e 5 . Co mp a r i s o n o f t h e d e t e c t i o n o f a d v a n c e d f i b r o s i s i n p a t i e n t s wi t h mi l d , mo d e r a t e ,  a n d s e v e r e s t e a t o s i s . T h e s e n s i t i v i t y f o r d e t e c t i n g a d v a n c e d f i b r o s i s wa s ma r k e d l y d e c r e a s e d b y s e  v e r e s t e a t o s i s i n t h e c a s e o f b o t h US a n d CT . 
T o e v a l u a t e wh e t h e r f i b r o s i s a n d o b e s i t y i n t e r f e r e d wi t h t h e d e t e c t i o n o f mo d e r a t e t o s e v e r e h i s t o l o g i c a l s t e a t o s i s b y US a n d CT , we a n a l y z e d 8 8 NAS H p a t i e n t s wi t h mo d e r a t e t o s e v e r e s t e a t o s i s . T o e v a l u a t e i n t e r f e r e n c e wi t h t h e d e t e c t i o n o f a d v a n c e d f i b r o s i s b y s t e a t o s i s a n d o b e s i t y , we a n a l y z e d 5 9 NAS H p a t i e n t s wi t h a d v a n c e d f i b r o s i s .
F i g u r e 2 . S c a t t e r d i a g r a m o f t h e l i v e r / s p l e e n a t t e n u a t i o n r a t i o o n CT i n r e l a t i o n t o t h e s e v e r i t y o f h i s t o l o g i c a l s t e a t o s i s . T h e r e wa s a s i g n i f i c a n t d i f f e r e n c e o f t h e l i v e r s p l e e n a t t e n u a t i o n r a t i o b e t we e n e a c h s t a g e o f s t e a t o s i s d
F i g u r e 3 . Co mp a r i s o n o f t h e d e t e c t i o n o f mo d e r a t e t o s e v e r e h i s t o l o g i c a l s t e a t o s i s b e t we e n p a t i e n t s wi t h mi l d f i b r o s i s a n d a d v a n c e d f i b r o s i s . T h e d e c r e a s e i n t h e s e n s i t i v i t y o f d e t e c t i n g mo d e r a t e t o s e v e r e h i s t o l o g i c a l s t e a t o s i s d u e t o t h e p r e s e n c e o f a d v a n c e d f i b r o s i s wa s s t a t i s t i c a l l y s i g n i f i c a n t f o r b o t h US a n d CT .
F i g u r e 4 . De t e c t i o n o f mo d e r a t e t o s e v e r e s t e a t o s i s b y US a n d CT a c c o r d i n g t o B MI . T h e s e n s i t i v i t y o f US f o r mo d e r a t e t o s e v e r e h i s t o l o g i c a l s t e a t o s i s wa s s i mi l a r i n e a c h B MI g r o u p . CT c o u l d mo r e a c c u r a t e l y i d e n t i f y t h e p r e s e n c e o f mo d e r a t e t o s e v e r e h i s t o l o g i c a l s t e a t o s i s i n o b e s e p a t i e n t s , b u t t h e d i f f e r e n c e wa s n o t s t a t i s t i c a l l y s i g n i f i c a n t .
S en s itiv ity fo r d etectio n o f a d v a n ced fib ro s is (% )
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F i g u r e 6 . S e n s i t i v i t y o f US a n d CT f o r a d v a n c e d f i b r o s i s i n r e l a t i o n t o B MI . T h e s e n s i t i v i t y o f b o t h US a n d CT f o r d e t e c t i n g a d v a n c e d f i b r o s i s d e c r e a s e d a s t h e B MI i n c r e a s e d . T h e l o s s o f s e n s i t i v i t y wa s s t a t i s t i c a l l y s i g n i f i c a n t f o r US .
